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Considerations on cardiac patients during Covid-19 outbreak
The ongoing coronavirus disease (Covid-19) pandemic has chal-
lenged globalized society to cope with the adoption of revolution-
ary healthcare measures. The severe acute respiratory syndrome 
coronavirus-2 (SARS-CoV-2) not only causes viral pneumonia but 
also acute myocardial injury and chronic damage to the cardiovas-
cular system.1 Currently, treating patients with cardiovascular dis-
ease (CVD) has become more challenging. A network of “hub” and 
“spoke” centers based on a system of specialized Covid-19 referral 
hospitals has been organized, in order to guarantee optimal medical 
care for patients with cardiac and noncardiac emergencies. Indeed, 
in Lombardy, Italy (the epicenter of the European outbreak), the ST-
elevation myocardial infarction (STEMI) regional network has been 
rearranged, reducing by more than 75% the number of previous 
“hub” centers with 24 hours a day—7 days a week capacity to per-
form primary percutaneous coronary interventions (PCI), with 13 
hospitals acting as “hubs” and other 42 acting as “spokes”.2 Generally, 
we have witnessed a drastic reduction of patients referring non-
Covid-19 related symptoms to the emergency department. The fear 
of contagion has caused a significant drop in improper admissions to 
the hospital facilities. In particular, national and international regis-
tries have reported a significant decrease in the number of admis-
sions for acute coronary syndromes (ACS), especially in northern 
Italy. Realistically, more and more people with ACS have not sought 
medical attention and have been left untreated, as it is confirmed 
by the increasing delayed presentations of ACS patients and their 
higher mortality. Therefore, an alarming increase in worse ACS out-
comes is expected in the near future.
The issue is amplified by the uncertain trend of this pandemic and 
by the unpredictable duration of the lockdown in some countries. 
Moreover, the limited mobility measures and the weak integration 
between hospitals and territorial medicine, especially in high-risk 
areas, constitute an additional concern. The most vulnerable Covid-
19-free subjects, such as patients with chronic cardiac disorders (ie, 
heart failure), have not routinely been followed-up in the hospital 
facilities during the pandemic. A rapid reorganization of cardiac ser-
vices and practical guidance on how to manage chronic patients are 
needed in the shortest time. Telemedicine and telecardiology, inte-
grated with the traditional management, appear to be precious tools 
for this emergent medical model, focused on the interplay between 
social, economic, environmental, and clinical factors. The flexible 
use of telematic devices, now available for teleconsultation and/or 
remote monitoring, allows the creation of integrated and personal-
ized management programs that are effective and efficient. Indeed, 
in order to minimize risks of in-hospital SARS-CoV-2 spreading, tele-
medicine should be adopted whenever possible, especially for frail 
and older patients. Telemedicine is crucial during this viral outbreak, 
preventing patients' health from deteriorating because of mistreated 
CVD while coping with the high infectious risks.3 Furthermore, tel-
erehabilitation should be considered as an option for patients dis-
charged from hospitals after an ischemic event and healthcare 
providers should be aware of innovative program delivery models. 
Both European and American Societies have shown to be up to 
the challenge, providing statements and recommendations on how 
to manage cardiac patients in these critical times,4,5 and, more im-
portantly, encouraging the rapid sharing of clinical experience and 
knowledge through any available sources (eg, webinars, free online 
access to nearly all medical resources).
One of the most burning issues has been the appropriate use 
of cardiovascular imaging in diagnosis and management of both 
Covid-19 and non-Covid-19 patients. It has become widely accepted 
that traditional cardiovascular risk factors, particularly older age, 
previous CVD, diabetes, and hypertension, increase significantly 
the risk of mortality in Covid-19 patients.1 Therefore, indications 
and recommended tests to assess cardiovascular function in sus-
pected or confirmed Covid-19 cases need to be standardized. The 
shared principles at the base of cardiovascular imaging are appro-
priateness of indication and diagnostic yield of the test, as well as 
choosing the most suitable, shortest and safest examination, both 
for patients and healthcare personnel. Transthoracic echocardiog-
raphy might be very useful in this setting, since it allows a bedside 
cardiac and respiratory assessment and remote assistance if needed, 
but unfortunately requires close contact with the patient. Therefore, 
Focused Cardiac Ultrasound Study (FoCUS), Ultrasound Assisted 
Physical Examination (UAPE), and Point Of Care Cardiac Ultrasound 
(POCUS), in accordance with American Society of Echocardiography, 
are recommending to reduce the duration of healthcare workers ex-
posure and to limit the use of additional resources, such as personal 
protective equipment (PPE). During this outbreak, special attention 
has to be dedicated to PPE, which has to be adequate to the risks 
(low/minimal: not suspected; moderate: suspected; high: confirmed), 
that should be evaluated before starting the examination. Therefore, 
careful planning and review of medical history are crucial to obtain 
complete diagnostic views, in order to avoid the need of subsequent 
additional images. Because of the high risk of aerosol generating 
procedures, transesophageal echocardiography should be replaced 
with alternative imaging modalities whenever possible. Computed 
tomography (CT) has gained attention, not only for its crucial role in 
confirming Covid-19 pneumonia, but also for the possible synergies 
and opportunities in evaluating cardiac morphology. Coronary CT 
showed to be accurate in the evaluation of both chronic coronary 
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syndromes and ACS6,7 and thus can provide noninvasive informa-
tions to solve doubtful situations, for example, unexplained eleva-
tion of cardiac troponins, (frequent finding in Covid-19 patients).
Cardiac magnetic resonance (CMR) may be provided also for 
urgent care in patients who have no known active Covid-19. When 
necessary, CMR in patients with confirmed or suspected SARS-
CoV-2 infections should be focused on the specific clinical question 
with an emphasis on myocardial function and tissue characteriza-
tion while optimizing patients and staff safety. CMR have had a 
marginal role so far during this pandemic, due to the long duration 
of the examinations and its limited availability. Nevertheless, in pa-
tients with confirmed SARS-CoV-2 infections and underlying CVD 
or myocardial injury, indications for CMR may evolve. Indeed, CMR 
may offer an effective choice to obtain critical information for clin-
ical decision-making, being the gold standard for evaluation of car-
diac function and tissue characterization. If cardiovascular imaging 
in Covid-19 patients could be challenging, the management of non-
Covid patients may be even more complicated. Both American and 
European Societies of Cardiology recommend the deferral or even 
the cancellation of elective nonurgent and routine follow-up visits, 
encouraging the use of telemedicine, in order to avoid SARS-CoV-2 
spreading and to protect healthcare workers. However, the triage 
of patients with CVD is seldom black or white: Many patients could 
overlook signs and symptoms of clinical worsening when reporting 
to physicians. Moreover, SARS-CoV-2 infections share symptoms 
with ACS, pulmonary embolism, and acute heart failure, like short-
ness of breath, fatigue, weakness, and sometimes chest pain.
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Severe acute respiratory syndrome coronavirus-2 infection has 
major implications for the cardiovascular system. Given the de-
crease in new Covid-19 cases worldwide, now, we are approaching 
the so-called “Phase 2” that represents a challenge that is leading to a 
gradual return to pre-Covid-19 life. The epidemiological and clinical 
situation is rapidly evolving and routine clinical practice depends on 
institutions and local availability. We expect a continue and progres-
sive update of the recommendations, which serve as general frame-
work in cardiac patients.
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